Intellia Therapeutics says its Crispr-based treatment succeeds in pivotal trial

Thread starter International: Top News And Analysis
Start date Monday at 1:48 PM

International: Top News And Analysis

Guest

Monday at 1:48 PM

Intellia Therapeutics said its Crispr-based treatment for hereditary angioedema met its goals in a Phase 3 trial, marking a milestone for gene editing.

Continue reading...

You must log in or register to reply here.

Facebook X Bluesky LinkedIn Reddit Pinterest Tumblr WhatsApp Email Link

Thread Information

Title: Intellia Therapeutics says its Crispr-based treatment succeeds in pivotal trial

Prefix: N/A

Forum: World News

Start date: Monday at 1:48 PM

Last reply date: Monday at 1:48 PM

Replies: 0

Thread Tags

Thread statistics

Created: International: Top News And Analysis, Monday at 1:48 PM

Replies: 0

Views: 2

About Us

XenTR Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.

It is a long established fact that a reader will be distracted by the readable content of a page when looking at its layout.

Color picker

Search